Australia: Health Alert: 5 March 2012

Last Updated: 11 March 2012
Article by Anthony Willis


Western Australia. State Administrative Tribunal

Medical Board of Australia and Wild [2012] WASAT 37 (27 February 2012)

The Medical Board of Australia brought an application in the State Administrative Tribunal of Western Australia (Tribunal) against Dr Felicity Wild, alleging that she acted improperly by having an inappropriate personal relationship with a patient and that she acted carelessly by leaving the patient while he was suffering from an overdose of morphine without seeking or providing medical assistance.

Dr Wild agreed that conditions should be imposed on her registration and the parties prepared Minutes of Orders prior to the hearing. These outlined a number of conditions to be placed on Dr Wild's registration, including (amongst others) only providing treatment at her practice during specific hours (unless in emergencies), only maintaining one set of clinical notes for each patient and holding these notes only at her practice, and certain supervision requirements.

The Tribunal found that Dr Wild acted improperly and carelessly and ordered that the conditions (as agreed) should be placed on Dr Wild's registration. The Tribunal also ordered that Dr Wild's registration be suspended for a period of three months. The Tribunal outlined that the purpose of the suspension was not to protect the public from an incompetent practitioner, but to assure the public and members of the medical profession that such conduct will not be tolerated.



National Health (IVF/GIFT Program) Special Arrangement Amendment Instrument 2012 (No. PB 9 of 2012) - F2012L00438 " PB 9 of 2012 as made

National Health (Growth Hormone Program) Special Arrangement Amendment Instrument 2012 (No. 1) (No. PB 8 of 2012) - F2012L00437 " PB 8 of 2012 as made

Health Insurance (Review of GP Mental Health Treatment Plan) Revocation Determination 2012 - F2012L00436 " as made

Australian Capital Territory

Transplantation and Anatomy Amendment Act 2012 (ACT) - Assent: 29 February 2012


Drugs, Poisons and Controlled Substances Amendment (Supply by Midwives) Bill 2012 - Legislative Assembly 28 February 2012: Introduced and read a first time


Australia. Department of Health & Ageing

Media releases

Private Health Insurance Circulars

Australia. Private Health Insurance Administration Council

2 March 2012 - Industry Consultation Opportunity - Proposed Outsourcing Standard for Private Health Insurers - Current Edition - 12/04

Australian Institute of Health & Welfare

2 March 2012 - National Bowel Cancer Screening Program monitoring report: phase 2, July 2008-June 2011 (media release)

Australian Competition & Consumer Commission (ACCC)

Capped fees for after-hours medical care in ACT to continue - The ACCC has authorised CALMS Ltd, the after-hours locum medical service which operates in the ACT.

Australia. Therapeutic Goods Administration

2 March 2012 - Poly Implant Prothese (PIP) breast implants - TGA update - Updated information on safety concerns with PIP breast implants.

2 March 2012 - Update to testing results of PIP breast implants - The Therapeutic Goods Administration (TGA) has increased the number of samples of PIP breast implants tested for shell integrity by measuring the tensile elongation of a further seven samples to the original eight samples that were tested in 201.0

2 March 2012 - Documents released under Section 11C of the Freedom of Information Act 1982 (Cth) - Added FOI 142-1112 documents.

1 March 2012 - King warns against internet medicine purchases - The Hon Catherine King MP.

1 March 2012 - Update to herbal ingredient names - A notice to sponsors on updating the names of ingredients that are currently included in medicines on the Australian Register of Therapeutic Goods (ARTG).

29 February 2012 - Conformity assessment procedures for immunohaematology reagents - This guideline addresses some specific requirements in the regulation of immunohaematology reagents that manufacturers and sponsors need to consider when applying conformity assessment procedures or making applications for inclusion in the ARTG.

29 February 2012 - Information about weight loss product - The TGA will be making a final decision on the weight loss product, the SUPPREXXA Hunger Buster kit, after consideration of material provided by the sponsor, Chika Health Pty Ltd, in support of the claims made about the kit.

Australian National Health & Medical Research Council

27 February 2012 - Australia/Singapore to host leaders in emerging infectious diseases - The brightest minds in emerging infectious diseases research and current technologies have gathered in Singapore for a scientific symposium to discuss the health challenges facing the Asia Pacific. A joint initiative between the National Health and Medical Research Council and the Singapore-based Agency for Science, Technology and Research, the symposium will focus on tuberculosis, influenza and how to combat them.

Australian Capital Territory. Department of Health

Media release

1 March 2012 - Emergency Services News Alerts - For the latest local information about the impact of the wet weather, please visit the ACT Emergency Services website.

27 February 2012 - Improve your health with BEAT IT! - Join the new BEAT IT: Physical Activity and Lifestyle Program, which kicks off on Wednesday 7 March in Bruce.

New South Wales. Ministry of Health

Media releases

Rural Surgery Futures Report 2011-2021

Information bulletin

Northern Territory. Department of Health

Media release

South Australia. Department of Health

Media releases

Tasmania. Department of Health & Human Services

Media releases

Victoria. Department of Health

2 March 2012 - Environmental sustainability and climate adaptation in healthcare - The Department of Health has adopted an overarching set of Sustainability Principles that commits it to respond to the challenges of a changing climate and embed sustainability within its core business.

1 March 2012 - Box Hill breakthrough for leukaemia patients - When Adam Bregu was diagnosed with cancer during the final stages of his VCE, he was determined to get through it – by being treated like a child.

Western Australia. Department of Health

Media releases

New Zealand. Ministry of Health

29 February 2012 - New Zealand Maternity Clinical Indicators 2009 - The New Zealand Maternity Clinical Indicators are an integral part of the Ministry of Health's Maternity Quality Initiative. These indicators are evidence-based and cover a range of procedures and outcomes for mothers and their babies. This benchmarked data will be used to support the local clinical review of maternity services.

28 February 2012 - The Environmental Case Management of Lead-Exposed Persons - These guidelines help public health units to determine the risk of a lead hazards and gives appropriate advice on managing the risk, including risk communication. These revised guidelines build on the 1998 and 2007 editions.

28 February 2012 - A Focus on Maori nutrition - This report presents key findings for Maori from the 2008/09 New Zealand Adult Nutrition Survey, including energy and nutrient intake, dietary supplement use, eating patterns, food security and nutritionrelated health (eg body size, blood pressure and diabetes).

28 February 2012 - A Focus on Pacific Nutrition - This report presents key findings for Pacific peoples from the 2008/09 New Zealand Adult Nutrition Survey, including energy and nutrient intake, dietary supplement use, eating patterns, food security and nutritionrelated health (eg body size, blood pressure and diabetes).

28 February 2012 - Guidance on Surveillance for People at Increased Risk of Colorectal Cancer - This guideline provides evidence-based surveillance recommendations for people at increased risk of colorectal cancer. It updates the 2004 publication Surveillance and Management of Groups at Increased Risk of Colorectal Cancer. It is intended for primary and secondary care providers.

28 February 2012 - Bowel cancer: information for people at increased risk of bowel cancer - Bowel cancer is the second-most common cancer in both men and women in New Zealand.

United Kingdom. Department of Health

Over £100 million given to support groundbreaking clinical research - Over £100m will be invested in NHS clinical research facilities to develop new treatments to benefit thousands of patients. The money, provided by the National Institute for Health Research, will be ... Read more – Over £100 million given to support groundbreaking clinical research

£22 million for ground-breaking children's mental health programme - Up to £22m will be pumped into a pioneering programme to give children with mental health problems access to the best available services in a wider range of places. The ... Read more – £22 million for ground-breaking children's mental health programme

New site to take you inside government - A new test version of a single website for government was made live today. "Inside government" is the corporate platform that will be for specialists seeking a "behind the scenes"... Read more – New site to take you inside government

UK Plan for rare diseases consultation launched - Earlier diagnosis of a rare condition and better coordinated care will help improve the quality of life for people with rare diseases and their families, according to the first ever ... Read more – UK Plan for rare diseases consultation launched

Paul Burstow to take part in Gransnet webchat - Minister for Care Services, Paul Burstow will be taking part in a live webchat on Gransnet, the social networking site for grandparents. The chat with the Minister and the Townswomen's ... Read more – Paul Burstow to take part in Gransnet webchat

Latest topics referred to NICE: January 2012 - Department of Health ministers agreed to refer the following topics to the National Institute for Health and Clinical Excellence (NICE) in January, to begin the process of developing guidance for ... Read more – Latest topics referred to NICE: January 2012

Webchat on autism - On Wednesday 7 March at 2pm, David Behan, Director General for Social Care, Local Government and Care Partnerships will host a webchat with Mark Lever, Chief Executive of the National Autistic Society on issues ... Read more – Webchat on autism

Acting FAST can save hundreds of lives - A campaign set to save the lives of stroke victims from across the country launches today. These hard hitting adverts, which will run until 25 March, aim to get people ... Read more – Acting FAST can save hundreds of lives

Government response to report on public expenditure - Today, the Government published its response to the Health Select Committee report on public expenditure. The Committee's report followed an inquiry into the implications for health and social care services ... Read more – Government response to report on public expenditure

United States of America. Department of Health & Human Services

1 March 2012 - Statement from Secretary Kathleen Sebelius on Women's History Month - Women's History Month is an important time of reflection and celebration for all Americans. We recognise the extraordinary accomplishments of women throughout history, and we celebrate the power of their vital contributions to shape our Nation's future.

29 February 2012 - HHS Statement on Cigarette Health Warning Ruling - This Administration is determined to do everything we can to warn young people about the dangers of smoking, which remains the leading cause of preventable death in America.

28 February 2012 - HHS Secretary Sebelius announces environmental justice strategy - Health & Human Services Secretary, Kathleen Sebelius, along with other federal agencies, today released the Department's 2012 Environmental Justice Strategy and Implementation Plan, outlining steps that will be taken to protect communities facing greater health and environmental risks.

24 February 2012 - Secretary Sebelius announces next stage for providers adopting electronic health records - Health and Human Services Secretary, Kathleen Sebelius today announced the next steps for providers who are using electronic health record technology and receiving incentive payments from Medicare and Medicaid.

© DLA Piper

This publication is intended as a general overview and discussion of the subjects dealt with. It is not intended to be, and should not used as, a substitute for taking legal advice in any specific situation. DLA Piper Australia will accept no responsibility for any actions taken or not taken on the basis of this publication.

DLA Piper Australia is part of DLA Piper, a global law firm, operating through various separate and distinct legal entities. For further information, please refer to

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

Some comments from our readers…
“The articles are extremely timely and highly applicable”
“I often find critical information not available elsewhere”
“As in-house counsel, Mondaq’s service is of great value”

Mondaq Advice Centre (MACs)
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at and we will use commercially reasonable efforts to determine and correct the problem promptly.